Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Gan & Lee Pharmaceuticals Co Ltd
603087Current price
46.38 CNY
0 CNY (0.00%)
Last closed
47.02 CNY
Company
www.ganlee.com
ISIN
CNE100003ZH1
Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
Shanghai Stock Exchange
Capitalization
30 020 619 326 CNY
Yield for 12 month
-3.80 %
1Y
3Y
5Y
10Y
15Y
603087
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company's products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection. It also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China. Address: No. 8, Nanfeng West 1st Street, Beijing, China, 101109
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
491.81 CNYP/E ratio
50.8163Dividend Yield
–Current Year
+2 615 667 864 CNY
Last Year
+1 717 280 468 CNY
Current Quarter
+756 766 418 CNY
Last Quarter
+561 973 705 CNY
Current Year
+1 916 205 853 CNY
Last Year
+1 310 289 293 CNY
Current Quarter
+559 341 147 CNY
Last Quarter
+409 278 771 CNY
Key Figures 603087
1 year
3 years
5 years
10 years
EBITDA
479 610 342 CNY
Operating Margin TTM
PE Ratio
50.8163
Return On Assets TTM
1.35 %
PEG Ratio
–
Return On Equity TTM
5.51 %
Wall Street Target Price
491.81 CNY
Revenue TTM
2 955 995 815 CNY
Book Value
18.18 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
37.6 %
Dividend Yield
–
Gross Profit TTM
1 272 050 077 CNY
Earnings per share
0.98 CNY
Diluted Eps TTM
0.98 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
48.5 %
Profit Margin
19.71 %
Dividend Analytics 603087
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 603087
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
18.06.2024
Forward Annual Dividend Yield
–
Last Split Factor
1.4:1
Payout Ratio
20.41 %
Last Split Date
20.08.2020
Dividend Date
–
Stock Valuation 603087
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
50.8163
Forward PE
–
Enterprise Value Revenue
8.3878
Price Sales TTM
10.1558
Enterprise Value EBITDA
65.0138
Price Book MRQ
2.6575
Financials 603087
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 603087
For 52 weeks
32.19 CNY
63.08 CNY
50 Day MA
44.58 CNY
Shares Short Prior Month
–
200 Day MA
44.54 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart